Access cutting-edge bladder cancer treatment through this clinical trial at a research site in Kansas City. Study-provided care at no cost to qualified participants.
Access bladder cancer specialists in Kansas City at no cost
This study follows strict safety protocols and ethical guidelines
All study-related bladder cancer treatment provided free
This is a phase II, single arm, Simon two-stage design, trial, enrolling patients with cisplatin ineligible MIBC and/or those patients who decline cisplatin based NAC. Assess rates of pathologic downstaging and quality of life in MIBC cisplatin-ineligible/declined patients when IVC is added to gemcitabine-carboplatin NAC.
Sponsor: University of Kansas Medical Center
Check if you qualify for this bladder cancer clinical trial in Kansas City, KS
If you're searching for bladder cancer treatment options in Kansas City, KS, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Kansas City research site is actively enrolling participants for this clinical trial. You'll receive care from experienced bladder cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.